+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Atrial Fibrillation Market Research Report by Device, by Product - United States Forecast to 2025 - Cumulative Impact of COVID-19

  • ID: 5122186
  • Report
  • July 2020
  • Region: United States
  • 83 pages
  • 360iResearch™
UP TO OFF
until Dec 31st 2020

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott Laboratories
  • AtriCure, Inc.
  • Johnson & Johnson
  • Medtronic plc
  • MORE
The United States Atrial Fibrillation Market is projected to grow with a significant CAGR in the forecast period. Economic development and substantial infrastructure development have constituted regional revenue generation. Further, the patterns associated with domestic production, import and export, and consumption have helped market participants to analyze and capitalize on potential opportunities. Besides, the qualitative and quantitative parameters provided in the report with detailed analysis highlights the driving and restraining factors of the United States Atrial Fibrillation Market.

Market Segmentation & Coverage:

This research report categorizes the Atrial Fibrillation market to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Device, the Atrial Fibrillation Market studied across Non-Surgical Devices and Surgical Devices. The Non-Surgical Devices further studied across Access Devices, Advanced Diagnostic Catheters, Cardiac Monitors, Conventional Diagnostic Catheters, Diagnostic Catheters, Electric Cardioversion, Intracardiac Echocardiography (ICE) Systems, Left Atrial Appendage and Closure Devices, and Mapping and Recording Systems. The Surgical Devices further studied across Catheter Ablation, Cryoablation, Laser Based Catheter Ablation, Maze Surgery, Microwave Based Catheter Ablation, Navigational Advanced Mapping Accessories, and Radiofrequency Catheter Ablation.

Based on Product, the Atrial Fibrillation Market studied across Access Devices, Cardiac Monitors or Implantable Loop Recorder, EP Ablation Catheters, EP Diagnostic Catheter, Intracardiac Echocardiography, Left Atrial Appendage Closure Devices, and Mapping and Recording Systems.

Company Usability Profiles:

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the United States Atrial Fibrillation Market including Abbott Laboratories, AtriCure, Inc., Boston Scientific Corporation, Johnson & Johnson, and Medtronic plc.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Atrial Fibrillation Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:

1. What is the market size and forecast of the United States Atrial Fibrillation Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Atrial Fibrillation Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Atrial Fibrillation Market?
4. What is the competitive strategic window for opportunities in the United States Atrial Fibrillation Market?
5. What are the technology trends and regulatory frameworks in the United States Atrial Fibrillation Market?
6. What are the modes and strategic moves considered suitable for entering the United States Atrial Fibrillation Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • AtriCure, Inc.
  • Johnson & Johnson
  • Medtronic plc
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome

3. Executive Summary
3.1. Market Outlook
3.2. Device Outlook
3.3. Product Outlook
3.4. Competitor Outlook

4. Market Overview
4.1. Introduction

5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Challenges

6. United States Atrial Fibrillation Market, By Device
6.1. Introduction
6.2. Non-Surgical Devices
6.2.1. Access Devices
6.2.2. Advanced Diagnostic Catheters
6.2.3. Cardiac Monitors
6.2.4. Conventional Diagnostic Catheters
6.2.4.1. Fixed Diagnostic Catheters
6.2.4.2. Steerable Diagnostic Catheters
6.2.5. Diagnostic Catheters
6.2.6. Electric Cardioversion
6.2.7. Intracardiac Echocardiography (ICE) Systems
6.2.8. Left Atrial Appendage and Closure Devices
6.2.9. Mapping and Recording Systems
6.3. Surgical Devices
6.3.1. Catheter Ablation
6.3.2. Cryoablation
6.3.3. Laser Based Catheter Ablation
6.3.4. Maze Surgery
6.3.5. Microwave Based Catheter Ablation
6.3.6. Navigational Advanced Mapping Accessories
6.3.7. Radiofrequency Catheter Ablation
6.3.7.1. Conventional RF Ablation Catheters
6.3.7.2. Irrigated-tip RF Ablation Catheters

7. United States Atrial Fibrillation Market, By Product
7.1. Introduction
7.2. Access Devices
7.3. Cardiac Monitors or Implantable Loop Recorder
7.4. EP Ablation Catheters
7.5. EP Diagnostic Catheter
7.6. Intracardiac Echocardiography
7.7. Left Atrial Appendage Closure Devices
7.8. Mapping and Recording Systems

8. Competitive Strategic Window
8.1. Introduction
8.2. Competitive Strategic Window, by Device
8.3. Competitive Strategic Window, by Product

9. Competitive Landscape
9.1. FPNV Positioning Matrix
9.1.1. Quadrants
9.1.2. Business Strategy
9.1.3. Product Satisfaction
9.2. Market Ranking Analysis
9.3. Market Share Analysis
9.4. Competitive Scenario
9.4.1. Merger & Acquisition
9.4.2. Agreement, Collaboration, & Partnership
9.4.3. New Product Launch & Enhancement
9.4.4. Investment & Funding
9.4.5. Award, Recognition, & Expansion

10. Company Usability Profiles
10.1. Abbott Laboratories
10.2. AtriCure, Inc.
10.3. Boston Scientific Corporation
10.4. Johnson & Johnson
10.5. Medtronic plc

11. Appendix
11.1. Discussion Guide
11.2. Edition Details
11.3. License Details
11.4. Pricing Details

LIST OF FIGURES
FIGURE 1. UNITED STATES ATRIAL FIBRILLATION MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES ATRIAL FIBRILLATION MARKET: RESEARCH EXECUTION
FIGURE 3. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, 2019 VS 2025 (USD MILLION)
FIGURE 4. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2019 VS 2025 (USD MILLION)
FIGURE 5. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2019 VS 2025 (USD MILLION)
FIGURE 6. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES ATRIAL FIBRILLATION MARKET, BY TYPE
FIGURE 7. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 8. UNITED STATES ATRIAL FIBRILLATION MARKET: MARKET DYNAMICS
FIGURE 9. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2019 VS 2025 (USD MILLION)
FIGURE 10. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2019 VS 2025 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2025 (USD MILLION)
FIGURE 12. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2025 (USD MILLION)
FIGURE 13. UNITED STATES ATRIAL FIBRILLATION MARKET: FPNV POSITIONING MATRIX
FIGURE 14. UNITED STATES ATRIAL FIBRILLATION MARKET: MARKET SHARE ANALYSIS

LIST OF TABLES
TABLE 1. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 2. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2017-2025 (USD MILLION)
TABLE 3. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY ACCESS DEVICES, 2017-2025 (USD MILLION)
TABLE 4. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY ADVANCED DIAGNOSTIC CATHETERS, 2017-2025 (USD MILLION)
TABLE 5. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY CARDIAC MONITORS, 2017-2025 (USD MILLION)
TABLE 6. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2017-2025 (USD MILLION)
TABLE 7. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY FIXED DIAGNOSTIC CATHETERS, 2017-2025 (USD MILLION)
TABLE 8. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY STEERABLE DIAGNOSTIC CATHETERS, 2017-2025 (USD MILLION)
TABLE 9. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY DIAGNOSTIC CATHETERS, 2017-2025 (USD MILLION)
TABLE 10. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY ELECTRIC CARDIOVERSION, 2017-2025 (USD MILLION)
TABLE 11. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY INTRACARDIAC ECHOCARDIOGRAPHY (ICE) SYSTEMS, 2017-2025 (USD MILLION)
TABLE 12. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY LEFT ATRIAL APPENDAGE AND CLOSURE DEVICES, 2017-2025 (USD MILLION)
TABLE 13. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY MAPPING AND RECORDING SYSTEMS, 2017-2025 (USD MILLION)
TABLE 14. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2017-2025 (USD MILLION)
TABLE 15. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY CATHETER ABLATION, 2017-2025 (USD MILLION)
TABLE 16. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY CRYOABLATION, 2017-2025 (USD MILLION)
TABLE 17. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY LASER BASED CATHETER ABLATION, 2017-2025 (USD MILLION)
TABLE 18. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY MAZE SURGERY, 2017-2025 (USD MILLION)
TABLE 19. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY MICROWAVE BASED CATHETER ABLATION, 2017-2025 (USD MILLION)
TABLE 20. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY NAVIGATIONAL ADVANCED MAPPING ACCESSORIES, 2017-2025 (USD MILLION)
TABLE 21. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2017-2025 (USD MILLION)
TABLE 22. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL RF ABLATION CATHETERS, 2017-2025 (USD MILLION)
TABLE 23. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY IRRIGATED-TIP RF ABLATION CATHETERS, 2017-2025 (USD MILLION)
TABLE 24. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY ACCESS DEVICES, 2017-2025 (USD MILLION)
TABLE 25. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY CARDIAC MONITORS OR IMPLANTABLE LOOP RECORDER, 2017-2025 (USD MILLION)
TABLE 26. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY EP ABLATION CATHETERS, 2017-2025 (USD MILLION)
TABLE 27. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY EP DIAGNOSTIC CATHETER, 2017-2025 (USD MILLION)
TABLE 28. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY INTRACARDIAC ECHOCARDIOGRAPHY, 2017-2025 (USD MILLION)
TABLE 29. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY LEFT ATRIAL APPENDAGE CLOSURE DEVICES, 2017-2025 (USD MILLION)
TABLE 30. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY MAPPING AND RECORDING SYSTEMS, 2017-2025 (USD MILLION)
TABLE 31. UNITED STATES ATRIAL FIBRILLATION MARKET: SCORES
TABLE 32. UNITED STATES ATRIAL FIBRILLATION MARKET: BUSINESS STRATEGY
TABLE 33. UNITED STATES ATRIAL FIBRILLATION MARKET: PRODUCT SATISFACTION
TABLE 34. UNITED STATES ATRIAL FIBRILLATION MARKET: RANKING
TABLE 35. UNITED STATES ATRIAL FIBRILLATION MARKET: MERGER & ACQUISITION
TABLE 36. UNITED STATES ATRIAL FIBRILLATION MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 37. UNITED STATES ATRIAL FIBRILLATION MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 38. UNITED STATES ATRIAL FIBRILLATION MARKET: INVESTMENT & FUNDING
TABLE 39. UNITED STATES ATRIAL FIBRILLATION MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 40. UNITED STATES ATRIAL FIBRILLATION MARKET: EDITION DETAILS
TABLE 41. UNITED STATES ATRIAL FIBRILLATION MARKET: LICENSE DETAILS
TABLE 42. UNITED STATES ATRIAL FIBRILLATION MARKET: PRICING DETAILS
Note: Product cover images may vary from those shown
  • Abbott Laboratories
  • AtriCure, Inc.
  • Boston Scientific Corporation
  • Johnson & Johnson
  • Medtronic plc
Note: Product cover images may vary from those shown
Adroll
adroll